megestrol acetate has been researched along with levonorgestrel in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 8 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Anhst-horridge, A; Richter, RH; Riemann-hunziker, R; Roth, F; Sprenger, S; Turpeinen, K | 1 |
| Del Giudice, M; Di Vagno, G; Greggi, S; Laurelli, G; Losito, S; Scaffa, C | 1 |
| Park, H; Seong, SJ; Yoon, BS | 1 |
| Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
| Ebrahimpour, B; Esrafili, A; Tajik, M; Yamini, Y | 1 |
| Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S | 1 |
| Di Napoli, M; Falcone, F; Granata, V; Greggi, S; Laurelli, G; Losito, S | 1 |
| Choi, YM; Kim, H; Kim, SH; Kim, SW; Ku, SY; Suh, CS | 1 |
| Gowri, V; Rawahi, TA; Shikeli, S | 1 |
| Christianson, MS; Cordeiro Mitchell, CN; Garbose, RA; Gornet, ME; Hunkler, KF; Maher, JY; Whiting-Collins, LJ | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
| Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
| Chen, X; Guan, J; Liao, J; Shan, W; Shao, W; Xu, Z; Yang, B | 1 |
| Chen, X; Guan, J; Liao, J; Luo, X; Ma, F; Ning, C; Shan, W; Shao, W; Wu, P; Xu, Z; Yang, B; Zhang, H; Zhou, S; Zhu, Q | 1 |
1 review(s) available for megestrol acetate and levonorgestrel
| Article | Year |
|---|---|
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
4 trial(s) available for megestrol acetate and levonorgestrel
| Article | Year |
|---|---|
Conservative treatment of early endometrial cancer: preliminary results of a pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Staging; Pilot Projects; Prospective Studies | 2011 |
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (Clini
Topics: Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Prospective Studies | 2023 |
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.
Topics: China; Endometrial Hyperplasia; Female; Fertility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Pregnancy; Prospective Studies | 2023 |
15 other study(ies) available for megestrol acetate and levonorgestrel
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Experience with three minipills preparations with low dose progestagens for oral contraception].
Topics: Behavior; Central Nervous System; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Digestive System; Disease; Family Planning Services; Hemorrhage; Levonorgestrel; Libido; Megestrol Acetate; Metrorrhagia; Nausea; Research; Sexual Behavior; Signs and Symptoms | 1970 |
The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility.
Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Megestrol Acetate | 2011 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
Automated hollow fiber microextraction based on two immiscible organic solvents for the extraction of two hormonal drugs.
Topics: Alkanes; Antineoplastic Agents, Hormonal; Calibration; Chromatography, High Pressure Liquid; Humans; Levonorgestrel; Liquid Phase Microextraction; Megestrol Acetate; Methanol; Organic Chemicals; Organophosphorus Compounds; Osmolar Concentration; Solvents; Urine; Water | 2015 |
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey | 2016 |
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Megestrol Acetate; Pregnancy; Progestins; Prospective Studies; Young Adult | 2017 |
A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Cryopreservation; Embryo Transfer; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Letrozole; Levonorgestrel; Live Birth; Megestrol Acetate; Neoplasm Recurrence, Local; Nitriles; Pregnancy; Pregnancy Outcome; Triazoles | 2018 |
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Treatment Outcome; Young Adult | 2020 |
Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
Topics: Adult; Carcinoma in Situ; Conservative Treatment; Contraceptive Agents, Female; Dilatation and Curettage; Endometrial Neoplasms; Female; Gynatresia; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Risk | 2021 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |